Results for "genetic mutation"
Conditions Encyclopedia Entry 1777139884
Cystic fibrosis (CF) is a chronic, progressive genetic disorder that affects the respiratory, digestive, and reproductive systems, causing severe damage and impairing the body's ability to function properly.
Health & MedicineConditions Encyclopedia Entry 1778698565
** This encyclopedia entry is about a rare genetic disorder known as **Erythromelalgia**, a condition characterized by burning pain, redness, and heat in the hands and feet. **CONTENT** ### Overview Erythromelalgia is a rare genetic disorder that affects the nervous system, causing burning pain, redness, and heat in the hands and feet. The condition is often described as feeling like walking on hot coals or having a severe sunburn. Erythromelalgia can be inherited or acquired, and its symptoms can vary in severity and impact daily life. People with erythromelalgia may experience episodes of pain and discomfort that can last from minutes to hours, and in some cases, the condition can be debilitating. Erythromelalgia is often misdiagnosed as other conditions, such as peripheral neuropathy, fibromyalgia, or vasculitis. However, a proper diagnosis can be made through a combination of medical history, physical examination, and diagnostic tests, including nerve conduction studies and skin biopsies. Treatment for erythromelalgia typically involves medications to manage pain and reduce symptoms, as well as lifestyle modifications to avoid triggers that can exacerbate the condition. ### History/Background Erythromelalgia was first described in the medical literature in the late 19th century, with the first reported case dating back to 1884. However, it wasn't until the 1960s that the condition was recognized as a distinct entity. Since then, research has focused on understanding the underlying causes of erythromelalgia, including genetic mutations and abnormalities in the nervous system. In 2010, the International Classification of Diseases (ICD) recognized erythromelalgia as a separate condition, acknowledging its distinct characteristics and symptoms. ### Key Information * **Prevalence:** Erythromelalgia affects approximately 1 in 100,000 people worldwide, although the exact prevalence is unknown due to underdiagnosis and misdiagnosis. * **Causes:** Erythromelalgia can be inherited or acquired, with genetic mutations and abnormalities in the nervous system contributing to the condition. * **Symptoms:** Burning pain, redness, and heat in the hands and feet, often accompanied by sweating and flushing. * **Diagnostic tests:** Nerve conduction studies, skin biopsies, and medical history to rule out other conditions. * **Treatment:** Medications to manage pain and reduce symptoms, lifestyle modifications to avoid triggers, and in some cases, surgery to relieve pressure on nerves. ### Significance Erythromelalgia is a significant condition that affects the quality of life for those affected. While it is rare, the condition can be debilitating and impact daily activities, relationships, and overall well-being. Research into erythromelalgia has contributed to our understanding of the nervous system and the development of new treatments for other conditions. Additionally, awareness and education about erythromelalgia can help healthcare professionals diagnose and manage the condition more effectively, improving outcomes for those affected. **INFOBOX** - Name: Erythromelalgia - Type: Rare genetic disorder - Date: 1884 (first reported case) - Location: Worldwide - Known For: Distinctive symptoms of burning pain, redness, and heat in the hands and feet **TAGS:** Rare genetic disorder, nervous system disorder, pain management, genetic mutation, vasculitis, peripheral neuropathy, fibromyalgia, vasculitis.
Health & MedicineConditions Encyclopedia Entry 1780073646
** Hypertrophic Cardiomyopathy (HCM) is a genetic heart condition characterized by the thickening of the heart muscle, which can lead to obstruction of blood flow and potentially life-threatening complications. **CONTENT:** ### Overview Hypertrophic Cardiomyopathy (HCM) is a complex and potentially life-threatening heart condition affecting approximately 1 in 500 people worldwide. It is the most common cause of sudden cardiac death in young athletes and is often inherited in an autosomal dominant pattern. HCM is characterized by the thickening of the heart muscle, particularly in the left ventricle, which can lead to obstruction of blood flow and potentially life-threatening complications. In HCM, the heart muscle becomes abnormally thick, which can cause the heart to work harder to pump blood. This can lead to a range of symptoms, including chest pain, shortness of breath, and fainting. In severe cases, HCM can lead to heart failure, arrhythmias, and even sudden cardiac death. ### History/Background The first reported cases of HCM date back to the 19th century, but it wasn't until the 1960s that the condition was formally described as a distinct entity. Since then, significant advances have been made in understanding the genetic and molecular mechanisms underlying HCM. In 1990, the first genetic mutation associated with HCM was identified, and since then, numerous other mutations have been linked to the condition. ### Key Information HCM is a genetic condition, meaning it is inherited from one's parents. The condition is caused by mutations in genes that code for proteins involved in the structure and function of the heart muscle. The most common genes associated with HCM are MYBPC3, MYH7, and TNNT2. Symptoms of HCM can vary widely, but common signs include: * Chest pain or discomfort * Shortness of breath * Fainting or near-fainting * Palpitations or irregular heartbeats * Fatigue or weakness In severe cases, HCM can lead to life-threatening complications, including: * Heart failure * Arrhythmias * Sudden cardiac death ### Significance HCM is a significant public health concern, particularly among young athletes and individuals with a family history of the condition. Early detection and treatment can significantly improve outcomes and prevent life-threatening complications. **INFOBOX:** - **Name:** Hypertrophic Cardiomyopathy - **Type:** Genetic heart condition - **Date:** First reported cases in the 19th century, formally described in the 1960s - **Location:** Worldwide - **Known For:** Most common cause of sudden cardiac death in young athletes **TAGS:** Hypertrophic Cardiomyopathy, genetic heart condition, sudden cardiac death, heart failure, arrhythmias, cardiomyopathy, heart muscle thickening, genetic mutation, MYBPC3, MYH7, TNNT2. **Seeking Professional Care:** If you or a family member is experiencing symptoms of HCM, it is essential to seek medical attention immediately. A diagnosis of HCM can only be made by a qualified healthcare professional, typically a cardiologist or geneticist. Treatment options may include medications, lifestyle modifications, and in some cases, surgical interventions. Early detection and treatment can significantly improve outcomes and prevent life-threatening complications.
Health & MedicineConditions Encyclopedia Entry 1781753045
** This encyclopedia entry is about a rare genetic disorder known as **Erythromelalgia**, a condition characterized by burning pain, heat, and redness in the hands and feet. ## Overview Erythromelalgia is a rare genetic disorder that affects the nervous system and blood vessels, causing a range of symptoms including burning pain, heat, and redness in the hands and feet. The condition is often described as feeling like walking on hot coals or being exposed to a flame. Erythromelalgia can be a debilitating condition, significantly impacting a person's quality of life. There are two main types of erythromelalgia: primary and secondary. Primary erythromelalgia is a genetic disorder, while secondary erythromelalgia is caused by an underlying medical condition, such as a blood disorder or a side effect of medication. The symptoms of erythromelalgia can vary in severity and may include: * Burning pain in the hands and feet * Redness and heat in the affected areas * Increased sensitivity to heat and cold * Swelling and inflammation * Numbness or tingling ## History/Background Erythromelalgia was first described in the medical literature in the late 19th century. However, it was not until the 1970s that the condition was recognized as a distinct genetic disorder. Since then, research has focused on understanding the underlying causes of erythromelalgia and developing effective treatments. In 2010, the National Institutes of Health (NIH) established a registry for individuals with erythromelalgia, which has helped to increase awareness and understanding of the condition. ## Key Information Erythromelalgia is a rare condition, affecting approximately 1 in 200,000 people worldwide. It is more common in women than men and typically begins in childhood or adolescence. The condition is caused by a mutation in the **SCN9A** gene, which codes for a protein involved in pain sensation. Researchers have identified several genetic variants associated with erythromelalgia, including a mutation in the **SCN9A** gene that is responsible for the majority of cases. Treatment for erythromelalgia typically involves a combination of medications and lifestyle modifications. Medications may include: * Anticonvulsants, such as gabapentin or pregabalin, to reduce pain * Anti-inflammatory medications, such as ibuprofen or naproxen, to reduce inflammation * Beta blockers, such as propranolol, to reduce blood flow to the affected areas Lifestyle modifications may include: * Avoiding heat and cold * Wearing loose, breathable clothing * Using cooling devices, such as fans or cold compresses * Engaging in regular exercise to improve circulation ## Significance Erythromelalgia is a significant condition because it can have a profound impact on a person's quality of life. The condition can cause significant pain and discomfort, making everyday activities challenging. Additionally, erythromelalgia can be a source of anxiety and depression, particularly if left untreated. Research into erythromelalgia has also shed light on the underlying mechanisms of pain sensation and blood vessel function, which has implications for the treatment of other conditions. INFOBOX: - Name: Erythromelalgia - Type: Rare genetic disorder - Date: 1970s (recognized as a distinct genetic disorder) - Location: Worldwide - Known For: Genetic mutation in the **SCN9A** gene TAGS: Erythromelalgia, genetic disorder, pain, heat, redness, rare condition, **SCN9A** gene, genetic mutation, pain sensation, blood vessel function, rare disease, genetic disorder, neurological disorder.
Health & MedicineConditions Encyclopedia Entry 1779267558
** This encyclopedia entry is about a rare and complex medical condition known as **Fibrodysplasia Ossificans Progressiva (FOP)**, a genetic disorder characterized by the gradual replacement of muscles, tendons, and other soft tissues with bone. **CONTENT:** ### Overview Fibrodysplasia Ossificans Progressiva (FOP) is a rare and debilitating genetic disorder that affects approximately 1 in 2 million people worldwide. It is a congenital condition, meaning it is present at birth, and is characterized by the abnormal development of bones and joints. FOP is caused by a mutation in the ACVR1 gene, which codes for a protein involved in the regulation of bone growth and development. This mutation leads to the formation of abnormal bone tissue in muscles, tendons, and other soft tissues, resulting in a gradual loss of mobility and function. FOP is a complex condition that affects multiple systems of the body, including the musculoskeletal, nervous, and circulatory systems. The symptoms of FOP can vary widely from person to person, but often include joint stiffness, muscle weakness, and limited mobility. In severe cases, FOP can lead to complete loss of mobility and independence. ### History/Background FOP was first described in the medical literature in 1868 by French physician Pierre Marie, who noted the condition's unique characteristics and proposed the term "fibrodysplasia ossificans progressiva." Over the years, FOP has been studied extensively, and researchers have made significant progress in understanding its genetic and molecular mechanisms. In 2006, a team of scientists identified the ACVR1 gene as the primary cause of FOP, paving the way for the development of new treatments and therapies. ### Key Information FOP is a rare and unpredictable condition, and its symptoms can vary widely from person to person. Some common symptoms of FOP include: * Joint stiffness and limited mobility * Muscle weakness and wasting * Abnormal bone growth and development * Limited range of motion * Respiratory problems due to chest wall deformities * Increased risk of fractures and osteoporosis FOP can be diagnosed through a combination of clinical evaluation, genetic testing, and imaging studies such as X-rays and CT scans. There is currently no cure for FOP, but various treatments and therapies can help manage its symptoms and slow its progression. These include physical therapy, pain management, and surgical interventions to correct deformities and improve mobility. ### Significance FOP is a rare and complex condition that affects the lives of individuals and families worldwide. Its significance lies in the need for continued research and awareness about this condition, as well as the development of new treatments and therapies to improve the quality of life for those affected by FOP. **INFOBOX:** - **Name:** Fibrodysplasia Ossificans Progressiva (FOP) - **Type:** Genetic disorder - **Date:** 1868 (first described) - **Location:** Worldwide - **Known For:** Rare and complex genetic disorder characterized by abnormal bone growth and development **TAGS:** Fibrodysplasia Ossificans Progressiva, FOP, genetic disorder, bone growth, muscle weakness, limited mobility, rare condition, genetic mutation, ACVR1 gene. **Important Note:** If you or a loved one has been diagnosed with FOP, it is essential to seek medical attention from a qualified healthcare professional. Early diagnosis and treatment can help manage symptoms and slow the progression of the condition.